首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Interleukin 1, a mediator of immunoadjuvant peptidoglycans
Authors:M Guenounou  F Vacheron  C Nauciel  
Institution:

1 Laboratoire de Microbiologie, UER de Médecine Paris Ouest, 92380, Garches, France

2 CNRS-ERA No. 396, Université Paris-Sud, 92290, Chatenay-Malabry, France

3 Immumochimie des Protéines, Institut Pasteur, France

Abstract:Bacterial peptidoglycans and the synthetic analog muramyl dipeptide possess various immunomodulating properties (adjuvant effect, increase of resistance to infectious agents and to tumor growth). They are able to induce B cell activation and to stimulate macrophages to produce monokines such as Interleukin 1 (IL 1). IL 1 plays an essential role in immune response. It promotes thymocytes maturation and Interleukin 2 secretion by antigen sensitive T cells, which in turn triggers regulatory T cells. Moreover, it is involved in the proliferation and differentiation of B cells.

There is a correlation between the immunoenhancing effect of PG of a definite structure and their ability to induce IL 1 secretion. Non-adjuvant PG were inactive. This suggests that one of the major mechanisms of action of adjuvant PG could be the stimulation of IL 1 synthesis.

Keywords:interleukin 1  macrophage  bacterial peptidoglycan  muramyl dipeptide  immunomodulationAuthor Keywords: interleukine 1  macrophage  peptidoglycane bactérien  immunomodulation
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号